Results 221 to 230 of about 83,920 (307)

Neoadjuvant endocrine therapy often leads to breast and axilla‐conserving surgery in stages II and III hormone receptor‐positive breast cancer patients: A registry study

open access: yesInternational Journal of Cancer, Volume 158, Issue 7, Page 1905-1915, 1 April 2026.
What's new? This study evaluated patient characteristics and treatment strategies in stages II and III HR+/HER2− breast cancer. Neoadjuvant systemic therapy frequently facilitated breast‐conserving procedures and less invasive axillary surgery. Approximately half of the patients undergoing primary surgery received a mastectomy, and all with positive ...
Layla Andour   +5 more
wiley   +1 more source

CK5/6 Expression in Molecular Subtypes of Invasive Ductal Carcinoma. [PDF]

open access: yesCureus
Yasin R   +7 more
europepmc   +1 more source

Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention

open access: yesInternational Journal of Cancer, Volume 158, Issue 7, Page 1927-1940, 1 April 2026.
What's new? Endocrine drugs repurposed from treatment protocols are the primary medications available for breast cancer (BC) prevention in at‐risk women. Adverse effects, however, significantly minimize uptake and prevention impact. Here, the authors investigated licochalcone A (LicA), a non‐endocrine anti‐inflammatory agent with reported hematologic ...
Atieh Hajirahimkhan   +14 more
wiley   +1 more source

Primary Mucinous Borderline Tumor of the Testis: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction Testicular mucinous borderline tumor is a rare primary testicular neoplasm with a generally favorable prognosis. Herein, we report a case diagnosed after high orchiectomy, with a brief literature review. Case Presentation A 77‐year‐old man presented with discomfort in the left scrotum.
Takeshi Shirota   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy